{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:43:48Z","timestamp":1777121028409,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1093\/annonc\/mdm439","type":"journal-article","created":{"date-parts":[[2007,9,11]],"date-time":"2007-09-11T00:12:47Z","timestamp":1189469567000},"page":"99-103","source":"Crossref","is-referenced-by-count":32,"title":["A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer"],"prefix":"10.1016","volume":"19","author":[{"given":"Y.J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-A.","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.Y.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.S.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.Y.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.B.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.J.","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm439_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer Statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdm439_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4143\/crt.2004.36.2.103","article-title":"Korea Central Cancer Registry. 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals","volume":"36","author":"Shin","year":"2004","journal-title":"Cancer Res Treat"},{"key":"10.1093\/annonc\/mdm439_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","article-title":"Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer","volume":"7","author":"Glimelius","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0025","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X","article-title":"Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer","volume":"54","author":"Falkson","year":"1984","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdm439_bb0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.1984.2.11.1245","article-title":"5-fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of biliary tract","volume":"2","author":"Harvey","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1023\/A:1008241008379","article-title":"Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin","volume":"9","author":"Ducreux","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0040","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/annonc\/mdf201","article-title":"Optimization of 5-fluorouracil\/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma","volume":"13","author":"Taieb","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/annonc\/mdi046","article-title":"Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma","volume":"16","author":"Thongprasert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0050","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/cncr.21741","article-title":"A phase II study of gemcitabine and cisplatin in advanced biliary tract cancer","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdm439_bb0055","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/annonc\/mdg281","article-title":"Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer","volume":"14","author":"Kim","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0060","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study","volume":"15","author":"Andre","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0065","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","article-title":"Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial","volume":"23","author":"Knox","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0070","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/cncr.21591","article-title":"Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced\/metastatic biliary tract carcinoma","volume":"104","author":"Cho","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdm439_bb0075","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/sj.bjc.6602208","article-title":"Phase II study of S-1 in patients with advanced biliary tract cancer","volume":"91","author":"Ueno","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdm439_bb0080","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1073\/pnas.83.23.8923","article-title":"Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian cancer cells","volume":"83","author":"Scanlon","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdm439_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00685830","article-title":"Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo","volume":"32","author":"Shirasaka","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdm439_bb0090","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/sj.bjc.6601413","article-title":"Phase I\/II study of S-1 combined with cisplatin in patients with advanced gastric cancer","volume":"89","author":"Koizumi","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdm439_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10147-004-0451-z","article-title":"A phase I\/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen","volume":"10","author":"Sato","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1200\/JCO.2005.04.2994","article-title":"Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma","volume":"24","author":"Ajani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0105","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1158\/1078-0432.CCR-04-1200","article-title":"S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial","volume":"10","author":"Ichinose","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdm439_bb0110","first-page":"115","article-title":"Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma","volume":"25","author":"Nakazawa","year":"2005","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1093\/annonc\/mdm439_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors (RECIST) guidelines","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdm439_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage design for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1093\/annonc\/mdm439_bb0125","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2005.05.3579","article-title":"Phase II study of erlotinib in patients with advanced biliary cancer","volume":"24","author":"Philip","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00280-006-0380-9","article-title":"Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer","volume":"60","author":"Hong","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdm439_bb0135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/annonc\/mdh172","article-title":"Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience","volume":"15","author":"Knox","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm439_bb0140","first-page":"1327","article-title":"Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice","volume":"17","author":"Yamada","year":"1990","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1093\/annonc\/mdm439_bb0145","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0959-8049(98)00211-1","article-title":"Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients","volume":"34","author":"Sakata","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdm439_bb0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000012032","article-title":"An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers","volume":"57","author":"Sugimachi","year":"1999","journal-title":"Oncology"},{"issue":"Suppl","key":"10.1093\/annonc\/mdm439_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10120-003-0230-y","article-title":"A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice","volume":"6","author":"Kimura","year":"2003","journal-title":"Gastric Cancer"},{"key":"10.1093\/annonc\/mdm439_bb0160","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0959-8049(03)00626-9","article-title":"A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting","volume":"39","author":"Hyodo","year":"2003","journal-title":"Eur J Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341941106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341941106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/1\/99\/435275\/mdm439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:16:36Z","timestamp":1582204596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341941106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S092375341941106X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm439","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}